On Ozempic or Mounjaro? The Blood Tests You Must Get Every 3 Months

GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have moved from diabetes clinics to dinner-table conversations across India. They genuinely help with weight loss and blood sugar control — but they are not "set and forget" injections. Without regular lab monitoring, side effects can creep up silently.

At Aarvak Diagnostics, we're seeing a steady rise in patients on these medications. Here's the monitoring panel doctors recommend every 3 months.

Why Monitoring Matters

GLP-1 drugs affect appetite, digestion, gallbladder function, kidney filtration, and muscle mass. Long-term users may face nutrient deficiencies, dehydration, or rare pancreatic and thyroid changes.

The Essential Quarterly Panel

• HbA1c & Fasting Glucose — confirm the metabolic benefit is working
• Lipid Profile — track cholesterol and triglyceride improvements
• Liver Function Test (LFT) — flag rare hepatic side effects
• Kidney Function Test (KFT) + Electrolytes — vomiting and reduced intake can affect kidneys
• Vitamin B12, Vitamin D, Iron Studies — eating less often leads to silent deficiencies
• TSH — baseline thyroid monitoring is recommended
• Lipase / Amylase — only if you have abdominal pain (rules out pancreatitis)

Watch for These Symptoms Between Tests

Persistent nausea, severe abdominal pain, dark urine, hair fall, or unusual fatigue all warrant an earlier check.

Smart Habits Alongside the Drug

• Hit a protein target (1.2–1.6 g/kg) to protect muscle mass
• Stay hydrated — at least 2.5 litres daily
• Don't skip resistance training
• Never share or buy GLP-1 pens from unverified sources

Book your GLP-1 monitoring panel at Aarvak Diagnostics with home sample collection across Gurugram.